Is Frequency Therapeutics, Inc. overvalued or undervalued?
As of March 18, 2025, Frequency Therapeutics, Inc. is considered risky and overvalued due to poor financial metrics and significant underperformance compared to the S&P 500, with a year-to-date return of -12.74% and a five-year decline of 97.34%.
As of 18 March 2025, the valuation grade for Frequency Therapeutics, Inc. has moved from does not qualify to risky, indicating a deteriorating outlook. The company appears to be overvalued given its financial metrics, including a Price to Book Value of 0.98, an EV to Sales ratio of 4.99, and an ROE of -62.91%. In comparison to peers, Frequency Therapeutics has a significantly negative EV to EBITDA of -0.26, while Surrozen, Inc. shows a more favorable EV to EBITDA of -0.3289.The stock has underperformed against the S&P 500, with a year-to-date return of -12.74% compared to the index's 12.22%, and over the past five years, it has declined by 97.34% while the S&P 500 gained 96.61%. This stark contrast reinforces the view that Frequency Therapeutics is currently overvalued.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
